American College of Clinical Pharmacy
      Search      Cart
         

Activity Details


Hematology/Oncology PRN Focus Session—Management of Endocrine Toxicities with Targeted Chemotherapy Agents

Monday, October 22, 2012 from 3:45 PM to 5:45 PM EDT at Diplomat Ballroom 3

Available for 2.00 hours of CPE credit
Activity Number: 0217-0000-12-103-L01-P
Activity Type: An Application-Based Activity


Speakers
  • Moderator: Christy S. Harris, PharmD, BCOP
    Associate Professor of Pharmacy Practice, School of Pharmacy-Boston, MCPHS University, Boston, Massachusetts
    View Biography

Hyperglycemia Management with Targeted Chemotherapy Agents
3:45 PM

Speakers
  • Speaker: Christine M. Walko, Pharm.D., BCOP, FCCP
    Associate Member, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, Florida
    View Biography


Learning Objectives
1. Evaluate the mechanisms by which hyperglycemia and hypothyroidism occur in patients on certain targeted chemotherapy agents.
2. Develop treatment recommendations for patients who develop these endocrine toxicities while on therapy.
3. Establish appropriate monitoring guidelines for patient receiving certain targeted chemotherapy agents.
Thyroid Dysfunction with Targeted Chemotherapy Agents
4:45 PM

Speakers
  • Speaker: John Bossaer, Pharm.D., BCOP, BCPS
    Assistant Professor, Pharmacy Practice, East Tennessee State University, Bill Gatton College of Pharmacy, Johnson City, Tennessee


Learning Objectives
1. Evaluate the mechanisms by which hyperglycemia and hypothyroidism occur in patients on certain targeted chemotherapy agents.
2. Develop treatment recommendations for patients who develop these endocrine toxicities while on therapy.
3. Establish appropriate monitoring guidelines for patient receiving certain targeted chemotherapy agents.